Clinical Characteristics and Outcome of 20 Imatinib Mesylate Resistant Patients with T315I BCR-ABL Mutation.
Year: 2007
Type: conference-abstract
Source: Blood
Authors: Wan-Seok Kim, Il-Young Kweon, Soo Hyun Kim, Hyun Gyung Goh, Jeong Lee, Se Eun Jung, Dongho Kim, Sa-Hee Park, Ji-Sun Lim, Ha-Na Kim, Dong-Wook Kim
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: T315I mutation, BCR-ABL, imatinib resistance, chronic myeloid leukemia, dasatinib, nilotinib, second-generation tyrosine kinase inhibitors, kinase domain mutations, treatment response, overall survival, progression-free survival, chronic phase, accelerated phase, blast crisis, interferon therapy, chromosomal abnormalities
Open Access status: closed
OpenAlex ID: W2581024504
